# CORRESP — Cue Biopharma, Inc.  (CUE)  (CIK 0001645460)

> <strong>Cue Biopharma, Inc.  (CUE)  (CIK 0001645460) → SEC staff</strong> · filed 2026-03-27 · ticker CUE · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001193125-26-129018
- **Form:** CORRESP
- **Filer:** Cue Biopharma, Inc.  (CUE)  (CIK 0001645460)
- **CIK:** 0001645460
- **Ticker:** CUE
- **Filed:** 2026-03-27
- **SIC industry:** 2834
- **HQ:** Boston, MA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1645460/000119312526129018/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1645460&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Cue Biopharma, Inc.  (CUE)  (CIK 0001645460)

- CORRESP — 2026-08-18 — /comment-letter/0001193125-26-355392
- UPLOAD — 2026-08-17 — /comment-letter/0000000000-26-008092
- CORRESP — 2026-06-29 — /comment-letter/0001193125-26-288417
- UPLOAD — 2026-06-25 — /comment-letter/0000000000-26-006372
- CORRESP — 2026-06-15 — /comment-letter/0001193125-26-271175
- UPLOAD — 2026-06-10 — /comment-letter/0000000000-26-005827
- UPLOAD — 2026-03-23 — /comment-letter/0000000000-26-002905

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Cue Biopharma, Inc.  (CUE)  (CIK 0001645460) (CIK 0001645460), filed 2026-03-27, accession 0001193125-26-129018. Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/comment-letter/0001193125-26-129018.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*